Skip to content

Nektar Therapeutics

US · NKTR #3017 by market cap Listed 1970
40.26 +0.35 +0.88%
Live - 5344 symbols - heartbeat 160s ago · 2026-10-08 07:38
Pre-market 39.20 -2.63%
After-hours 40.00 -0.65%
Overnight 40.20 -0.15%
Market cap
1.37B
P/B
1.52
EPS
-9.73
Reader sentiment Are you bullish or bearish on NKTR?

Anonymous reader poll. Unscientific, not investment advice.

Nektar Therapeutics ended the session at 40.26, up 0.88%. Its market capitalisation is about 1.37B, the #3017 most valuable US-listed company we track. Wall Street's 9-analyst consensus lands on Buy, with a price target averaging 155.57 (+286% from here). Against a 52-week band of 33.40-109.00, the shares are currently 9% of the way up.

✦ StockVane Quant Insights how this is computed

Quant Rating E Strong Sell
  • Below its 200-day average and near the bottom of the universe on momentum.
  • Signal has read STRONG SELL for 1 day.
  • Its last 3 Sell calls were followed by a 9% average decline over the next quarter.
See the full rating history & follow-along return →
Quant Sentiment Bearish
  • Recent price momentum is -38.4% on average (3-month/1-year).
  • Main-fund capital flow has been a net outflow over the last 45 sessions.
  • Short interest has risen to 16.8% of float.
  • Analyst tilt is Buy.
Quant Technical Outlook Bearish
  • Price is below its 20-day average and below its 60-day average.
  • The 20-day average is below the 60-day average, a short-term downtrend.

Computed by a StockVane algorithm from historical price, valuation and analyst data - not a person, not a forecast guarantee, and not investment advice.

Price chart

100.3539.9140.262026-04-092026-10-07
MA5MA10MA20MA60
— MA5 — MA10 — MA20 — MA60

Performance

1W -33.51%
1M -45.73%
3M -46.25%
6M -47.19%
YTD -4.78%
1Y -30.59%
3Y +397.04%
5Y -84.06%

Key statistics

Price & volume

Prev close
39.91
Open
39.22
Day range
38.45 - 40.35
Avg price
39.57
Volume
1.51M
Turnover
59.77M
Amplitude
4.77%
52-week range
33.40 - 109.00

Valuation

P/E
-4.14
P/E (TTM)
-6.58
P/B
1.52
EPS
-9.73
Net profit
-332.21M
Net assets
903.12M

Share structure

Market cap
1.37B
Float cap
1.14B
Shares out
34.14M
Float shares
28.28M

Dividend & listing

Dividend (TTM)
0.00
Listing date
1970-01-01
52-week range 9% of range
33.40 109.00

63.1% below the 52-week high

Trading activity

Net capital flow main funds, last 45 sessions

-20.46M net over the window

Short interest

Shares short
5.74M
As of
2026-09-15

Frequently asked questions

What is the current stock price of Nektar Therapeutics (NKTR)?

Nektar Therapeutics last traded at 40.26. The quote on this page refreshes every few seconds while US markets are open.

What is Nektar Therapeutics's market cap?

About 1.37B.

What is the P/E ratio of Nektar Therapeutics?

The trailing twelve-month P/E is -6.58. The Valuation tab shows it against the stock's own five-year range.

Does Nektar Therapeutics pay a dividend?

Nektar Therapeutics does not currently pay a regular dividend.

Is Nektar Therapeutics a buy according to analysts?

The consensus of 9 analysts is a Buy rating, with an average 12-month price target of 155.57, which implies 286.4% upside from the current price. This is not investment advice.

What is Nektar Therapeutics's StockVane Quant Rating?

The StockVane Momentum strategy currently rates Nektar Therapeutics a E (Strong Sell). Below its 200-day average and near the bottom of the universe on momentum. Not investment advice.

Quote time 2026-10-08 07:38:31 · For reference only, not investment advice and not tailored to your situation.